Literature DB >> 14714895

Glycodynamics of mucin biosynthesis in gastrointestinal tumor cells.

Inka Brockhausen1.   

Abstract

Glycoproteins found in the secretions and on the surfaces of cancer cells include mucins and mucin-like glycoproteins. These molecules have been shown to carry antigens that are characteristically expressed on cancer cells, including Tn and T antigens and Lewis epitopes. The structures of O-glycans are often abnormal in gastrointestinal tumors, or else are present in abnormal amounts, and these structures greatly contribute to the phenotype and biology of cancer cells. It has been shown that glycans of cancer cells have functional importance in cell adhesion, invasion and metastasis. The possible mechanisms leading to these cancer-specific changes in carbohydrate structures (termed glycodynamics) involve altered mRNA expression and catalytic activities of glycosyltransferases and sulfotransferases found in tissues and cells of gastrointestinal tumors. In a number of cases it has been possible to correlate enzyme changes with oligosaccharide structures. Different mechanisms have been suggested leading to the synthesis of cancer-specific Lewis, T and Tn antigens, but the regulation of cancer mucin antigens generally appears to be very complex and is poorly understood. The expression levels of specific mucin antigens and enzymes in gastro-intestinal tumors have diagnostic as well as prognostic value. These antigens also have potential for cancer immunotherapy. However, we first need to unravel the complexity of the control of glycosylation in cancer cells. Most importantly, studies of the functional implications of the glycodynamics in cancer cells, as related to cell adhesion and impact on the immune system will provide promising directions for future research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14714895     DOI: 10.1007/978-1-4615-0065-0_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

Review 1.  Intestinal candyfloss.

Authors:  Inka Brockhausen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

2.  Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.

Authors:  Raymond P Brinãs; Andreas Sundgren; Padmini Sahoo; Susan Morey; Kate Rittenhouse-Olson; Greg E Wilding; Wei Deng; Joseph J Barchi
Journal:  Bioconjug Chem       Date:  2012-07-31       Impact factor: 4.774

Review 3.  Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions.

Authors:  Inka Brockhausen
Journal:  EMBO Rep       Date:  2006-06       Impact factor: 8.807

Review 4.  Specificity in cancer immunotherapy.

Authors:  Andrea Schietinger; Mary Philip; Hans Schreiber
Journal:  Semin Immunol       Date:  2008-08-05       Impact factor: 11.130

5.  Gastric mucus alterations associated with murine Helicobacter infection.

Authors:  Julia M Schmitz; Carolyn G Durham; Samuel B Ho; Robin G Lorenz
Journal:  J Histochem Cytochem       Date:  2009-01-19       Impact factor: 2.479

Review 6.  Eukaryotic protein glycosylation: a primer for histochemists and cell biologists.

Authors:  Anthony Corfield
Journal:  Histochem Cell Biol       Date:  2016-12-23       Impact factor: 4.304

Review 7.  The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human.

Authors:  Anthony P Corfield
Journal:  Microorganisms       Date:  2018-08-02

Review 8.  Mucins and Pathogenic Mucin-Like Molecules Are Immunomodulators During Infection and Targets for Diagnostics and Vaccines.

Authors:  Sandra Pinzón Martín; Peter H Seeberger; Daniel Varón Silva
Journal:  Front Chem       Date:  2019-10-22       Impact factor: 5.221

9.  Structural Characterization of Mucin O-Glycosylation May Provide Important Information to Help Prevent Colorectal Tumor Recurrence.

Authors:  Adriana Mihalache; Jean-François Delplanque; Bélinda Ringot-Destrez; Cindy Wavelet; Pierre Gosset; Bertrand Nunes; Sophie Groux-Degroote; Renaud Léonard; Catherine Robbe-Masselot
Journal:  Front Oncol       Date:  2015-10-08       Impact factor: 6.244

10.  State of the art in tumor antigen and biomarker discovery.

Authors:  Klervi Even-Desrumeaux; Daniel Baty; Patrick Chames
Journal:  Cancers (Basel)       Date:  2011-06-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.